Menogaril

Known as: 7-O-Methylnogarol, 7-con-O-methylnorgarol, Menogaril [Chemical/Ingredient] 
A semisynthetic derivative of the anthracycline antineoplastic antibiotic nogalamycin. Menogaril intercalates into DNA and interacts with… (More)
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
To examine the influence of estradiol on muscle damage and leg strength after intense eccentric exercise. Eight men (MEN), eight… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
2004
2004
AIM Subjects, 28 recreational male and female novice and experienced Tae Kwon Do practitioners (age 19-42 years), were examined… (More)
Is this relevant?
2002
2002
This study, conducted at the Exercise Physiology Laboratory of Auburn University, AL, addressed and compared the acute… (More)
Is this relevant?
1989
1989
A new model to predict antitumor activity of new analogues was developed, and the cross-resistance against cisplatin (CDDP) and… (More)
  • table 1
  • figure 1
  • table 4
  • table 2
  • table 3
Is this relevant?
Highly Cited
1987
Highly Cited
1987
A multidrug resistant variant (H69AR) of the human small cell lung cancer cell line NCI-H69 was obtained by culturing these cells… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
1987
1987
We performed a phase I study of menogaril to determine if dosage reduction was required in patients with hepatic dysfunction and… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
1986
1986
Thirty-three adult patients with solid tumors were treated with menogaril, a new anthracycline antibiotic. The drug was given as… (More)
Is this relevant?
1986
1986
In a Phase I study, menogaril (7-OMEN) was administered daily for 5 days/course, every 21-28 days. Dosages of 3.5, 7, 11.5, 17… (More)
  • figure 1
  • figure 2
  • table 1
  • figure 5
  • figure 7
Is this relevant?
1984
1984
Menogaril [menogarol, 7(R)-O-methymogarol, 7-OMEN] is a new anthracycline agent which was chosen for clinical trials based on: a… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
Is this relevant?
1980
1980
The drugs studied included nogalamycin and its derivative 7-con-O-methylnogalarol, dis-nogamycin and its derivative 7-con-O… (More)
  • table 1
  • table 2
Is this relevant?